Sharon Cresci, MD

crescisDr. Sharon Cresci received her bachelor of science with honors in biochemistry from the State University of New York Binghamton and her medical degree with honors from New York University School of Medicine. She pursued internal medicine internship and residency at Bellevue Hospital in New York, where, after her third year, she was selected as the senior chief resident for the program.

After residency, she completed her fellowship in cardiology at Washington University. She extended the research component of her fellowship, training more than five years in Dr. Daniel Kelly’s laboratory studying the transcriptional regulation of genes involved in cardiac metabolism. During this time, she was awarded two grants, an American Heart Association Fellowship Award in 1993 and a National Research Service Award from the National Institutes of Health (NIH) from 1994 to 1996.

In 1997, Dr. Cresci had to take a hiatus from research due to family obligations and therefore joined Washington University as a part-time clinical faculty member. During this time, she had a clinical focus in echocardiography and remained active in teaching. In the two years prior to her return as a full-time faculty member, Dr. Cresci spent time training with Dr. Howard McLeod in oncology, learning pharmacogenomics, and worked closely with Dr. Kelly to generate data in support of a successful major application for SCCOR funding.

Dr. Cresci returned to the full-time faculty of internal medicine in 2007, continuing her focus on cardiovascular genomics and translational work in pharmacogenomics. She is currently an assistant professor of medicine on the tenure tract in the Department of Internal Medicine.

Sharon is the principle investigator of an NIH RO1 award entitled “Genomic variants associated with angina and health status outcome after MI.” She is the director of the Applied Genomics Core Laboratory for the multicenter TRIUMPH (Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients’ Health status) study of the Cardiovascular Outcomes Research Consortium. She has more recently become an active collaborator on the National Heart, Lung and Blood Institute (NHLBI)-sponsored Exome Sequencing Program (ESP) Myocardial Infarction (MI) Project Team.